Cancer
Immunotherapy Enhances Effectiveness of KRAS-Targeted Treatments in Pancreatic Cancer
In a groundbreaking study that has the potential to reshape the treatment landscape for pancreatic cancer, researchers from the Perelman...
Researchers Unlock Method to Reactivate Cancer’s Molecular ‘Kill Switch’
In a groundbreaking study published in Nature Communications, researchers from The Jackson Laboratory and UConn Health have revealed the intricate...
Announcing the ESMO Sarcoma and Rare Cancers Congress 2025: A Key Event for Advancements in Oncology
Lugano, Switzerland, is set to host a pivotal event in the field of oncology, the ESMO Sarcoma and Rare Cancers...
Impact of Postnatal Depression on the Oxytocin System in Breastfeeding Mothers
The oxytocin system plays a crucial role in the physiological and emotional landscape of motherhood, particularly during breastfeeding. A recent...
Groundbreaking Therapeutic Advancements for Pediatric Brain Tumors
Brain tumors represent the leading cause of cancer-related mortality among children, with pediatric high-grade gliomas (pHGG) standing out as a...
Pitt Research Unveils New Insights into the Origins of Ovarian Cancer
Researchers from the University of Pittsburgh have unveiled a groundbreaking discovery that may radically change our understanding of ovarian cancer's...
Cellular Circuit Regulates DNA Repair Mechanisms, Influencing Disease Risk with Age
Title: Unraveling the Cellular Mystery: How p53 Proteins Combat Aging and Inflammation In the dynamic and intricate world of cellular...
FDA-Approved Drug Reimagined for Potential High-Grade Glioma Treatment
High-grade glioma represents a particularly aggressive form of brain cancer, affecting both pediatric and adult populations. This type of tumor...
Breakthrough Research by Mayo Clinic Uncovers Proteins Associated with Immunotherapy Resistance in Metastatic Colorectal Cancer
The latest research emerging from the Mayo Clinic offers significant insights into the challenges faced in treating metastatic colorectal cancer...
Faeth Therapeutics and The Gog Foundation, Inc. Unveil Phase 2 Combination Trial of Sapanisertib and Serabelisib for Endometrial Cancer Patients
FAETH THERAPEUTICS AND THE GOG FOUNDATION, INC. LAUNCH FIRST PHASE 2 COMBINATION TRIAL FOR SAPANISERTIB-SERABELISIB IN PATIENTS WITH ENDOMETRIAL CANCER...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!